Localization of a yeast early Golgi mannosyltransferase, Och1p, involves retrograde transport by unknown
Localization of a Yeast Early Golgi Mannosyltransferase, Ochlp, Involves 
Retrograde Transport 
Sandra L. Harris and M. Gerard Waters 
Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544 
Abstract. To analyze the mechanism of integral mem- 
brane protein localization in the early Golgi apparatus 
of Saccharomyces cerevisiae, we have used Ochlp, a cis- 
Golgi mannosyltransferase. A series of influenza virus 
hemagglutinin (HA) epitope-tagged fusion proteins 
was constructed in which invertase is appended to the 
Golgi-luminal carboxy terminus of full-length Oehlp. 
Several constructs included a Kex2p cleavage site be- 
tween the Ochlp and invertase moieties to monitor 
transit to the Kex2p-containing TGN. Cells expressing 
an Ochlp-invertase fusion do not secrete invertase, but 
those expressing an Ochlp-Kex2p site-invertase fusion 
protein secrete high levels of invertase in a Kex2p- 
dependent manner. The Ochlp-Kex2p site-invertase 
fusion protein is cleaved with a half-time of 5 min, and 
the process proceeds to completion. Before cleavage 
the protein receives glycosyl modifications indicative of 
passage through the medial- and trans-Golgi,  therefore 
cleavage occurs after ordered anterograde transport 
through the Golgi to the TGN. Transit to distal com- 
partments is not induced by the invertase moiety, since 
noninvertase fusion constructs encounter the same gly- 
cosyltransferases and Kex2p as well. The Ochlp-HA 
moiety, irrespective of whether it is generated by cleav- 
age of the fusion protein in the TGN or synthesized de 
novo, is degraded with a half-time of about 60 min. 
Thus, the half-time of degradation is 12-fold longer 
than the time required to reach the TGN. At steady 
state, de novo--synthesized and TGN-generated HA 
epitope-tagged Ochlp reside in a compartment with a 
buoyant density identical to that of wild-type Ochlp 
and distinct from that of the vacuole or the TGN. Fi- 
nally, ochl null cells that express an Ochlp fusion con- 
struct known to rapidly encounter the TGN glycosylate 
invertase to the same extent as wild-type cells, indicat- 
ing that they have phenotypically  wild-type Ochlp ac- 
tivity. These results lead us to propose a model for 
Ochlp-HA localization that involves movement to dis- 
tal compartments, at least as far as the TGN, followed 
by retrieval to the cis compartment, presumably by ve- 
sicular transport. 
T 
HE eukaryotic secretory pathway consists of a set of 
membrane-bound compartments that are involved 
in delivery of newly made proteins to their final des- 
tinations. The hub of this pathway is the Golgi apparatus, 
which is involved in the posttranslational modification and 
sorting of the proteins that pass through it. The Golgi is 
composed of several topologically distinct cisternae, each 
of which contains a unique set of resident proteins. These 
proteins must resist dispersion by the large flux of vesicu- 
lar traffic to and from the Golgi apparatus. This process is 
as important as the initial delivery of proteins to this or- 
ganelle, yet it is not well understood. For example, it is not 
known whether newly made Golgi proteins simply cease 
their forward movement upon reaching the correct cister- 
nae, or whether they are  localized  by a  more dynamic 
mechanism involving recycling through later compartments. 
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An active  recycling mechanism has been shown to be 
operative for ER luminal proteins that possess  the car- 
boxy-terminal  tetrapeptide  sequence  Lys-Asp-Glu-Leu 
(KDEL; HDEL in  yeast)  (63), as  well  as  ER  integral 
membrane proteins (IMP)  I that bear a cytoplasmic  dily- 
sine motif K(X)KXX (42, 43, 101) at their carboxy termini. 
These proteins sometimes escape the ER in transport vesi- 
cles, perhaps because of failure of a static retention mech- 
anism, and are delivered to the Golgi apparatus. A KDEL 
receptor resides in the Golgi (94), where it apprehends the 
escapees  and escorts them back to the confines of the ER 
(52).  Once  in the ER,  the  protein is  released, and  the 
KDEL receptor returns to the early Golgi (109). In a simi- 
lar fashion, the et subunit of the coatomer complex  (41, 
103)  is  likely to  be  involved  in  recovery  of  wayward 
K(X)KXX-bearing proteins (17, 51) from the Golgi to the ER. 
1. Abbreviations used in this paper. CPY, carboxypeptidase Y; DPAP A, 
dipeptidyl aminopeptidase A; HA, influenza virus hemagglutinin; IMP, 
integral membrane protein; IP, immunoprecipitation; ManT, mannosyl- 
transferase; SD, synthetic dextrose. 
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much less is known about the mechanism of protein reten- 
tion in the Golgi apparatus. Although the scattered Golgi 
apparatus of Saccharomyces  cerevisiae  is morphologically 
distinct  from  its  stacked  mammalian  counterpart,  it  is 
quite similar biochemically, and therefore provides an ex- 
cellent model system for analysis of Golgi protein reten- 
tion.  Several  lines  of  evidence  indicate  that  the  yeast 
Golgi, like that of mammalian cells, is composed of dis- 
tinct compartments. For example, the sequential matura- 
tion of oligosaccharides in the yeast Golgi requires  the 
SEC18  gene  product  (yeast  N-ethylmaleimide-sensitive 
fusion protein, NSF) at multiple stages, indicating that the 
modification enzymes are sequestered in functionally and 
topologically distinct compartments (31).  Localization of 
Golgi resident proteins  by indirect immunofluorescence 
(26)  and subcellular fractionation (9,  11, 18, 28, 105) also 
reveals that different Golgi enzymes reside in separable 
compartments. Similarly, transport  of pro-a-factor from 
the ER to the Golgi in vitro results in only the earliest gly- 
cosyl modification, indicating that the glycosyl transferases 
used at later steps are not contained within the acceptor 
compartment (4, 34). In sum, these and other studies indi- 
cate that the yeast Golgi can be subdivided into at least 
four compartments.  The  ER-proximal,  or  cis,  compart- 
ment  contains  the  initiating  ~t-l,6-mannosyltransferase 
(ManT), Ochlp (28, 65), which is responsible for addition 
of the first mannose residue to the core oligosaccharides 
obtained in the ER (64, 80). The next, or medial, compart- 
ment  contains the  elongating o~-l,6-ManT  activity (28). 
The terminal et-l,3-ManT, encoded by MNN1  (77), is con- 
tained within the equivalent of the trans-Golgi and TGN 
(31, 33). The TGN, which is the most distal Golgi compart- 
ment, also contains the Kex2p, Kexlp, and DPAP A pro- 
teases (11, 18, 25, 31). 
Most  known residents  of the  cis-,  medial-,  and trans- 
Golgi are type II IMPs, with their amino termini in the cy- 
toplasm and their carboxy termini in the Golgi lumen. (A 
recently described exception is Emp47, which is a Type I 
IMP of the yeast medial-Golgi [88]). In contrast, TGN res- 
idents are generally type I IMPs with the opposite topol- 
ogy. Much effort has been directed towards identifying  the 
"Golgi retention signal" of early type II proteins. Many 
studies indicate that the transmembrane domain is critical 
(2,  14, 32, 39, 57, 89, 98, 99,  111)  with some researchers 
finding that the adjacent regions are also involved (15, 19, 
58, 59, 62, 66, 83, 100, 104). However, several groups have 
argued that retention is conferred by multiple domains of 
the molecule (3, 7, 12, 32, 54, 90). For example, in yeast, 
the transmembrane domain of Mnnlp can localize a heter- 
ologous protein to the Golgi; nevertheless, a soluble form 
of Mnnlp, completely lacking a transmembrane domain, is 
also localized to the Golgi (32). Thus, there may be multi- 
ple  signals  involving  cytoplasmic,  membrane-spanning, 
and luminal domains that act together to affect the proper 
localization of Golgi proteins. 
In contrast to the complex retention signals of type II 
cis,  medial,  and trans  residents, the  retention signals of 
three type I residents of the yeast TGN are well defined: 
they are located in the carboxy-terminal cytoplasmic tails, 
contain critical aromatic residues, and are similar to the 
signals within mammalian cell surface receptors that medi- 
ate clustering into clathrin-coated pits (107).  Elimination 
of the cytoplasmic tails of the TGN proteases DPAP A, 
Kex2p, or Kexlp destroys retention and results in trans- 
port to the vacuole (16, 69, 106). In addition, loss of clath- 
rin function in yeast results in mislocalization of Kex2p 
and DPAP A  to the plasma membrane (91).  It was sug- 
gested, therefore, that clathrin binding to the cytoplasmic 
tails of Kex2p or DPAP A was necessary for either direct 
retention or recycling of late Golgi enzymes (91). 
Localization of the type I proteins to the TGN and type 
II proteins to the earlier compartments appears to occur 
via different mechanisms. First, clathrin may not be  di- 
rectly required for localization of early Golgi proteins be- 
cause GDPase, a type II early Golgi protein, is not mislo- 
calized in a  ctathrin mutant (92).  In contrast, Mnnlp, a 
type II enzyme that seems to have dual citizenship in both 
the  trans-Golgi  and  TGN  of yeast, is mislocalized in  a 
clathrin mutant (33). However, this effect is not mediated 
through the cytoplasmic tail of Mnnlp (33), and it may be 
due to a more indirect effect on TGN structure or function 
in clathrin mutants. Second, the early and late Golgi reten- 
tion mechanisms differ in their saturability. For example, 
overexpression of the type I proteins Kex2p or DPAP A 
causes a significant fraction of the protein to mislocalize to 
the vacuole (69, 106), whereas the Golgi seems to be able 
to readily localize overexpressed Mnnlp, which is a type II 
protein (32).  Behavior of Mnnlp is more similar to mam- 
malian  glycosyltransferases, which  upon  overexpression 
are predominately correctly localized, although ER accu- 
mulation is sometimes observed (62, 66, 97). Finally, early 
type II and late type I retention systems appear to be dis- 
tinct because overexpression of Mnnlp does not alter the 
turnover of Kex2p, suggesting that the proteins  are  not 
competing for a common component (33). 
Several  mechanistic  models  have  been  proposed  for 
Golgi protein localization (10, 55, 67). Probably the most 
widely held view, first proposed by Swift and Machamer 
(97),  is that Golgi proteins form aggregates that are too 
large to enter forward-moving transport vesicles and are 
thus retained (53, 68, 90, 97, 104). This model requires that 
aggregation be induced at a particular point during Golgi 
transit, perhaps by some physiochemical property of par- 
ticular Golgi subcompartments. A  related model, called 
the "kin recognition model" (67, 68), posits that different 
resident proteins of a particular cisternae interact to form 
large  heterooligomers  that  restrict  forward  movement, 
possibly by anchoring to a Golgi matrix (96).  Yet a third 
model is based on two observations: first, that Golgi pro- 
tein transmembrane domains are shorter, in general, than 
those of plasma membrane proteins (10), and second, that 
a cholesterol concentration gradient seems to exist in the 
mammalian secretory pathway (72), with the ER being rel- 
atively depleted  and  the  plasma  membrane  being  rela- 
tively enriched. Cholesterol tends to thicken lipid bilayers, 
hence the proposal that proteins transit the secretory path- 
way until their transmembrane domains "fit" the thickness 
(35)  of the surrounding bilayer. Premature retention or 
continued movement forward would be energetically un- 
favorable due to the hydrophobic effect. One of the fea- 
tures common to all these models is that once a protein 
reaches its correct subcompartment within the Golgi, it is 
postulated to cease its forward movement and be retained. 
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Ochlp, a cis-Golgi ManT, using a series of influenza virus 
hemagglutinin (HA) epitope-tagged Ochlp-invertase fu- 
sion proteins (see Fig. 1). In contrast to most current mod- 
els, we have found that the Ochlp fusion proteins do not 
efficiently halt their forward movement upon encounter- 
ing the cis compartment. Instead, they move to later Golgi 
compartments, at least as far as the TGN, after which they 
return to the cis compartment. Our results indicate that 
yeast possesses a retrograde transport pathway from the 
TGN to the cis compartment, and furthermore, that local- 
ization of HA epitope-tagged Ochlp  to the cis-Golgi at 
steady state is due, at least in part, to recycling from later 
Golgi cisternae. 
Materials and Methods 
Strains and Media 
The Escherichia coli strains used were XL1-Blue (supE44 thi-1 lac endA1 
gyrA96  hsdR17  relA1  [F' proAB laclq ZAM15 Trd0])  (Stratagene, La 
Jolla,  CA)  and  BMH  71-18  (thi  supE  A[lac-proAB]  [mutS::TnlO] [F' 
proAB, laclq ZAM15]) (48). Bacterial strains were grown on standard me- 
dia (61).  S. cerevisiae strains used were SEY6210 (MATa, ura3-52, leu2- 
3,112, his3-,~200, trpl-A901, lys2-801, suc2A9) (79), SHY101 (  MA Ta, ura3- 
52,  trplA1,  leu2-3,112, ade2-101, AochI::LEU2)  (this  study),  SHY102 
(MATa  ura3-52,  leu2-3,112,  his3-A200,  trpl-A901,  lys2-801,  suc2A9, 
kex2 A2":HlS3-s) (this study), SHY103 ( MA Ta, ura3-52, 1eu2-3,112, his3- 
A200, trpl-A901,  lys2-801, suc2A9, pep4d::LEU2)  (this study) and SH104 
(  MA Ta, lys2-801, ura3-52, 1eu2-3,112, ade2-101, trp  l A1, suc2A9, secl  8-1) 
(this study). Yeast strains were grown on yeast extract, peptone, and dextrose 
or on synthetic dextrose (SD) medium supplemented as necessary (81). 
Piasmid Construction and Site-directed Mutagenesis 
To create plasmid pSEC18 (URA3, CEN), the BamHI-HindIII SEC18- 
containing fragment from plasmid pSEY8-SEC18 (2 ~m) (22), kindly pro- 
vided by S. Emr (University of California, San Diego), was subcloned into 
the yeast CEN-containing  shuttle vector pRS416 (95) that had also been 
digested with BamHI and HindIII. Plasmid pKEX2-HA (TRP1, CEN) 
was made by snbcloning the KEX2-HA-bearing SalI/Eagl fragment from 
pSN218 (70),  kindly provided by T. Stevens (University of Oregon, Eu- 
gene), into the yeast CEN-containing  shuttle vector pRS414 (95) that had 
been digested with SalI and EagI. The KEX2 gene on pKEX2-HA con- 
tains the sequence encoding three repeated copies of the 9-amino acid 
epitope (YPYDVPDYA) from HA protein (110).  Plasmid pSH113 was 
created by digesting pBL-OCH1, generously provided by Y. Jigami (Na- 
tional Institute of Bioscience and Human Technology, Tsukuba, Japan) 
(65), with XcmI followed by incubation with T4 DNA polymerase to yield 
blunt ends. The linearized plasmid was then digested with NsiI and ligated 
to a  SmaI-PstI LEU2 fragment from pMR2253, kindly provided by M. 
Rose (Princeton University, Princeton, NJ). This created a complete dele- 
tion of the OCH1 open reading frame. 
Plasmid pO, which encodes Ochlp, was created by inserting the 2.6-kb 
XhoI-HindIII OCH1  fragment from pBL-OCH1  into pRS416.  Plasmid 
pO-HindIII was  made  by introducing a  HindIII  site at  the codon for 
amino acid 472 (of the 480 amino acid Ochlp) by unique site elimination 
site-directed mutagenesis (20).  Plasmid pOI, which encodes the first 472 
amino acids of Ochlp fused in frame to amino acid 2 of mature invertase, 
was created by ligating the SUC2-containing HindlII-PvuII fragment from 
plasmid pSEY306 (44) to pO-HindIII that had been digested with HindIII 
and SaclI. The amino acid sequence in single letter code at the Ochlp-- 
invertase fusion ioint encoded by pOI is KEAST (where K is amino acid 
470 of Ochlp and T is amino acid 2 of mature invertase). Plasmid pOKI 
encodes, at the junction between Ochlp and invertase, six amino acids 
from pro-a-factor (MYKREA) that contain the dibasic recognition site 
for the Kex2 protease. Plasmid pOKI was created by site-directed mu- 
tagenesis of the  pOI  plasmid  using  a  mutagenic  oligonucleotide that 
spanned OCH1 and SUC2. In one round of mutagenesis, the HindIII site 
at the junction of OCH1 and SUC2 was removed, amino acids 472-478 of 
Ochlp were restored, the Kex2 (MYKREA) cleavage site was added, and 
a NheI site was created. The sequence present at the fusion junction en- 
coded by pOKI is: G (amino acid 478 of Ochlp) AS (encoded by the NheI 
site) MYKREA (Kex2p cleavage site) M (amino acid 1 of mature inver- 
tase). 
To construct vectors encoding HA epitope-tagged proteins, we inserted 
a  sequence encoding three repeated copies of the epitope (YPYDVP- 
DYAG) from HA (110). First, a NheI site was added to the carboxy ter- 
minus of Ochlp by site-directed mutagenesis of plasmid pO resulting in 
the replacement of amino acids 479 and 480 (HK) with the amino acids 
AS in pO-NheI. To make pOH, a 100-bp fragment encoding the triple HA 
epitope sequence was removed from plasmid pMR2654 (kindly provided 
by M. Rose) by digestion with XbaL The XbaI fragment was ligated into 
the NheI site of pO-NheI. The sequence at the carboxy terminus of Ochlp 
encoded by pOH is G  (amino acid 478 of Ochlp) AR YPYDVPDYAG 
YPYDVPDYAGSYPYDVPDYASS.  Similarly,  the  same  100-bp  HA 
epitope-encoding XbaI fragment was ligated into the NheI site of plasmid 
pOKI to create pOHKI (URA3). The fusion junction between Ochlp and 
invertase encoded by pOHKI is G (amino acid 478 of Ochlp) AR YPYD- 
VPDYAG  YPYDVPDYAG  SYPYDVPDYASS  MYKREA  (cleavage 
site) M (amino acid 1 of mature invertase), pOHKI (TRP1) was created 
by digesting pOHKI (URA3) with XhoI and SaclI and ligating the OCH1- 
SUC2--containing fragment into pRS414 (TRP1 CEN) (95) that had been 
digested with XhoI and Sacll. Plasmid pOKH, created by site-directed 
mutagenesis of plasmid pOH,  encodes an Ochlp fusion protein whose 
carboxy terminus is appended with the Kex2 cleavage site followed by 
the triple HA epitope. The sequence at the carboxy terminus of Ochlp 
encoded by pOKH is G (amino acid 478 of Ochlp) SS MYKREA (cleav- 
age site) YPYDVPDYAG YPYDVPDYAG SYPYDVPDYASS. All mu- 
tations were verified by DNA sequence analysis by the dideoxy method (85). 
Yeast and Bacterial Methods 
E. coli transformations were performed using the method of Hanahan 
(36). Yeast transformations were performed by the method of Schiestl and 
Gietz (87) with the modifications of Eible (23). To create the Aochl strain, 
SHY101, a XhoI-HindIII ochl::LEU2-containing  fragment from plasmid 
pSHll3 (described above) was integrated into diploid strain SHY100 (a/a, 
ura3-52/ura3-52, ade2-1OllADE2,  leu2-3,112/leu2-3,112, TRP1/trplA1) by 
one-step gene replacement (82). After sporulation, temperature-sensitive 
Leu ÷ haploid segregants were isolated that contained a complete deletion 
of the OCH10RF. Deletion of OCH1 was confirmed by PCR (84) using 
oligonucleotide primers flanking the deletion. SHY102 was created from 
SEY6210 by one-step gene replacement of KEX2 with the BamHI frag- 
ment containing the kex2A2::HlS3-s  allele from plasmid pKX::HIS3-s, 
kindly provided by R. Fuller (University of Michigan, Ann Arbor). Dele- 
tion of KEX2 was confirmed by a decrease in mating efficiency of the null 
strain. SHY103 was created from SEY6210 by one-step gene replacement 
of PEP4 with the BamHI fragment containing the pep4A:.'LEU2  allele 
from plasmid pTS17  (kindly provided by T.  Stevens). The  deletion of 
PEP4 was confirmed by the inability of the cells to proteolytically process 
carboxypeptidase Y to its mature form (27, 47). 
Invertase activity was determined by the method of Goldstein and 
Lampen (29)  with the modifications for measurement of periplasmic ac- 
tivity presented in Johnson et al. (44). 
Production of  Anti-Ochlp Antisera 
The gene fragment ranging from the Hpal site to the NsiI site of OCH1 
was cloned behind the gene encoding the maltose binding protein in the 
vector pMAL-c2 (New England Biolabs, Beverly, MA). The recombinant 
protein that included amino acids 71 to 480 of Ochlp was expressed in E. 
coli and purified on an amylose column according to the manufacturer's 
direction. The purified recombinant protein was used for immunization of 
a rabbit according to standard procedures (37). 
Protein Extraction and Immunoblotting 
Yeast protein extracts for immunoblotting were prepared from 1 ml of 
midlogarithmic phase (OD600 am  =  0.5--1.0)  cells grown in SD media con- 
taining appropriate supplements. Cells were washed in water and then re- 
suspended in 0.2 ml 5% TCA. Glass beads (0.45-p.m diam) were added to 
about three-fourths of the total sample volume. Cells were lysed by vor- 
texing for five 1-min periods, alternating with l-rain incubations on ice. 
The lysates were removed from the beads and centrifuged for 15 min in a 
microfuge at 4°C. TCA-precipitated protein was resuspended in Laemmli 
Harris and Waters Golgi Protein Recycling  987 sample buffer (50), heated at 100°C for 4 min, and separated on an 8% 
SDS-polyacrylamide gel. Immunoblots, which were developed with the 
enhanced chemiluminescence detection kit (Amersham Corp., Arlington 
Heights, IL), were performed according to standard methods (37).  HA 
epitope-tagged Ochlp and Kex2p were detected with 12CA5 hybridoma 
serum-free culture supernatant at a dilution ranging from 1:250 to 1:1000. 
Mouse monoclonal antibody 10D7-A7-B2 (21), which recognizes the yeast 
vacuolar H+-ATPase 100 kD subunit, was used at a concentration of 250 
ng/ml (Molecular Probes, Eugene, OR). 
Radiolabeling and Immunoprecipitation 
Yeast were grown in SD media lacking uracil, cysteine, and methionine at 
30°C (unless otherwise indicated) to an OD600 nm =  0.5-1.0. 30D  U  of 
cells per time point were washed in SD lacking uracil, cysteine, and me- 
thionine and resuspended in 1 ml of the same media. Cells were pulse la- 
beled with 150 p~Ci of Tran~SS-label (ICN Radiochemicals, Irvine, CA) 
per 3 OD U of ceils for 2 min at 30°C (unless otherwise noted). Labeling 
was quenched by addition of a 25 ×  chase solution (250 mM methionine, 
250 mM cysteine) to a final concentration of IX. The chase was stopped 
by addition of NaN3 to 10 mM and cycloheximide to 1OO p~g/ml  on ice. The 
cells were centrifuged, and the pellets were resuspended in 1OO p.l of bead 
buffer (50 mM Tris-HCl, pH 7.4,  100 mM NaCI, 2 mM EDTA, 1% SDS, 
and  1  mM PMSF).  Glass beads  (0.45-1xm  diam)  were  added  to  about 
three-fourths of the total sample volume, and cells were disrupted by vor- 
texing for five l-rain intervals separated by l-rain cooling periods on ice. 
The lysate was removed, and the beads were washed with 150 ttl of bead 
buffer. The lysate and wash were combined and incubated at 100°C for 4 
min, centrifuged (12,OO0 g) for 10 rain to remove insoluble material, and 
added to 750 ~1 of immunoprecipitation (IP) dilution buffer (60 mM Tris- 
HCI, pH 7.4, 190 mM NaC1, 6 mM EDTA, 1.25% Triton X-1OO, and I mM 
PMSF). To precipitate HA epitope-tagged protein, 2OO I~1 per 3 OD U of 
cells of 12CA5 hybridoma serum-free culture supernatant was added. To 
precipitate CPY, 0.6 ixl of rabbit polyclonal anti-CPY per 3 OD U of cells 
were added. Antibody to CPY was a gift from S. Emr. Immunoprecipita- 
tion of invertase used 9 p.l of rabbit polyclonal anti-invertase, provided by 
M. Rose, per 3 OD U  of cells. 20 p~l of a 50% slurry of protein A~Seph- 
arose CL-4B (Pharmacia, Piscataway, NJ) in IP buffer (50 mM Tris-HCl, 
pH 7.4, 150 mM NaC1, 5 mM EDTA, 1% Triton X-1OO, 0.2% SDS) was 
added, and the immune complexes were allowed to form overnight at 4°C 
while slowly mixing. Sepharose-bound immune complexes were pelleted 
(12,000 g, 1 rain) and washed sequentially in 1 ml each of high salt wash 
buffer (50 mM Tris-HCl, pH 7.4, 500 mM NaCI, 1% Triton X-1OO, 0.2% 
SDS), IP buffer, and detergent-free buffer (50 mM Tris-HCl, pH 7.4, 150 
mM NaC1, 5 mM EDTA). Immunoprecipitated protein was resuspended 
in Laemmli buffer (50), incubated at 100°C for 4 min, and separated on an 
8%  SDS-polyacrylamide gel. Gels were fixed in 25% isopropanol, 10% 
acetic acid for 15 min, treated  with Amplify (Amersham Corp.)  for  15 
min, dried, and exposed to film (X-AR5; Eastman-Kodak Co., Rochester, 
NY) at -70°C. 
Antigens to be reimmunoprecipitated with a second antibody were dis- 
sociated from the first antibody by incubation at 1OO°C for 10 rain in the 
presence of 100 ~1 of 1% SDS. 9OO/~1 of IP dilution buffer was added to 
the eluted antigen. 5 p.l of polyclonal antisera specific to tx-l,6-- or et-l,3- 
linked mannose residues were added, and the immune complexes were al- 
lowed  to  form  overnight  at  4°C  with  gentle  mixing. Complexes were 
washed and processed as described above. The linkage-specific antibodies 
(5) were provided by R. Schekman (University of California, Berkeley). 
SubceUular Fractionation 
Yeast strain SHY102 (Akex2) expressing HA epitope-tagged KEX2 on a 
TRP CEN plasmid was transformed with either the pOH (URA3) or pOHKI 
(URA3) plasmid. The two strains were grown in 250 ml of SD lacking 
uracil and tryptophan at 30°C to an OD600 nm of 0.5-0.8, harvested by cen- 
trifugation, and washed two times in spheroplast buffer (50 mM Tris-HCl, 
pH 7.5,  1.2 M  sorbitol, 10 mM NAN3, 40 mM 13-mereaptoethanol). Cells 
were resuspended in spheroplast buffer at 40 OD U/ml. Zymolyase 100T 
(ICN, Costa Mesa, CA) was added to 150 Ixg/ml, and cells were incubated 
at 30°C for 30 min with occasional mixing. The spheroplasts were washed 
two times in spheroplast buffer and resuspended in 0°C lysis buffer (20 
mM Hepes/KOH, pH 7.4,  100 mM K-acetate, 5 mM Mg(acetate), 1 mM 
EDTA, 1 mM Dq'T) plus 2 mM EGTA, 1 mM PMSF, 5 mM 1,10-phenan- 
throline, 2 IxM pepstatin A, 2 p.g/ml aprotinin, 0.5 Ixg/ml leupeptin to the 
same volume in which they were spheroplasted. Cells were lysed in a 7-ml 
Dounce homogenizer (25 strokes of "B" pestle; Kontes Glass Co., Vine- 
land, NJ) on ice, and the lysates were centrifuged in a rotor (SA600; Sor- 
vail Instruments Div., DuPont Co., Newton, CT) at 4°C for 3 rain at 3,300 
rpm (1OO0  g). The resulting supernatants (S1) were centrifuged in a Sor- 
vail SA6OO rotor at 4°C for 15 rain at 10,OO0  g to generate pellet (P10) and 
supernatant (S10) fractions. The $10 fractions (1.3 ml) were loaded onto 
the tops of 10.5-ml continuous 25--40%  sucrose (wt/wt) gradients and cen- 
trifuged in a rotor (SW4I; Beckman Instruments, Fullerton, CA) at 40,000 
rpm at 4°C for 18 h. 15 0.75-ml fractions were collected starting from the 
bottom of the gradient. 
To localize wild-type Ochlp, SEY6210 cells were grown in SD media 
lacking cysteine and methionine at 30°C to an OD~00 of 0.5-1.0. 20 OD U 
of cells were washed in SD lacking cysteine and methionine and resus- 
pended in 12 ml of the same media. Cells were pulse labeled with 50 g,  Ci 
of Tran35S-label per OD of cells for 2 min at 30°C. Labeling was quenched 
by addition of a 25x  chase solution (250 mM methionine, 250 mM cys- 
teine) to a final concentration of 1 ×. Cells were incubated at 30~C for 60 
min after which the chase was stopped by addition of NaN  3 to 10 mM and 
cycloheximide to 100 p~g/ml on ice. An additional 60 OD U of unlabeled 
SEY6210 cells that had been washed two times in spheroplast buffer were 
added to the labeled cells. The cells were then spheroplasted and lysed, 
and the protein  was fractionated on a  25-40%  sucrose gradient as de- 
scribed above. The protein in 0.65 ml of each fraction was immunoprecip- 
itated using 1 ixl of the rabbit polyclonal anti-Ochlp antisera per fraction. 
Immunoprecipitations were performed as described above. 
Results 
Rationale 
Most models of protein retention within the Golgi appara- 
tus propose a  static mechanism whereby proteins fail to 
move forward upon reaching their resident compartment 
(10,  67),  although  retrieval mechanisms  have  been  dis- 
cussed (32, 40, 56). In the light of recent data suggesting a 
recycling component to  the  localization  mechanisms  of 
ER (28, 74, 101) and TGN resident proteins (108), as well 
as  a  type  I  IMP  in  the  medial-Golgi  of yeast  (88),  we 
thought it was possible that localization of type II IMPs 
within the Golgi stacks might also involve retrieval of pro- 
teins that have escaped to more distal compartments. To 
examine this question, we chose to use Ochlp because its 
activity represents the first post-ER enzymatic event re- 
quired for synthesis of outer-chain mannose linkages on 
yeast secretory proteins, and thus Ochlp must reside in a 
very early Golgi compartment (64, 80). This cis-Golgi lo- 
calization has recently been confirmed by Gaynor et al. 
(28). To monitor the trafficking of Ochlp, it was fused to 
the reporter enzyme invertase, which is  encoded by the 
SUC2 gene (Fig. 1). Secretion of invertase into the yeast 
periplasm is necessary for cells to use sucrose as a carbon 
source (13). A  recognition site for the Kex2 protease was 
included at the junction of Ochlp and invertase to monitor 
passage of the fusion protein into the Kex2p compartment, 
or  TGN.  The  amino  acid  sequence  encoding  the  Kex2 
cleavage site  (MYKREA)  was  derived  from  the MFal 
gene (49). MF~I encodes a precursor protein that transits 
the secretory pathway and is proteolytically processed by 
several enzymes in the TGN to yield mature a-factor pher- 
omone, which is secreted from the cell (27, 78). The Kex2p 
endopeptidase cleaves on the carboxyl side of the KR se- 
quence found in the a-factor peptide (1, 45). 
We reasoned that if a static retention mechanism exists 
for Ochlp, then the Ochlp-Kex2 site-invertase fusion pro- 
tein would remain in the cis-Golgi. This anchoring would 
result in a Suc- phenotype in suc2A9 cells because the fu- 
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invertase fusion proteins used in this study. All proteins were ex- 
pressed  from the OCH1 promoter on low copy number (CEN) 
plasmids, aa, amino acid residue. 
sion would not travel to the TGN. Thus, the invertase moi- 
ety could not be released by Kex2p, and subsequent move- 
ment to the cell surface would be prohibited. If, however, 
the fusion protein was capable of movement to the TGN, 
then Kex2p would release the invertase moiety, allowing 
the enzyme to travel to the cell surface resulting in a Suc  ÷ 
phenotype. Therefore, the ability of various Ochlp-Kex2 
site-invertase fusion proteins to confer a Suc  ÷ phenotype 
to suc2A9 cells would be the first test of whether Ochlp is 
capable of movement to more distal Golgi compartments. 
A similar method has recently been used to study localiza- 
tion of Sec12p (8), a  protein that cycles between the ER 
and Golgi, as well as Mnnlp (32), a glycosyltransferase lo- 
calized to the trans-Golgi  and TGN. 
To detect Ochlp as well as the various fusion proteins 
by Western blot analysis and IP, we epitope tagged several 
of the proteins (Fig. 1) with the HA epitope recognized by 
the mAb, 12CA5 (110). All proteins were expressed from 
single-copy centromere-based (CEN) plasmids under the 
control  of  the  wild-type  OCH1  promoter.  All  Ochlp 
epitope-tagged molecules and fusion proteins used in this 
study are capable of complementing the temperature-sen- 
sitive defect (65) of the ochl null strain (Table I), suggest- 
ing that the proteins are properly folded and correctly lo- 
calized. 
Table L Kex2p-dependent Secretion of  lnvertase 
Complementation 
Aochl  Suc + in  Suc + in 
Construct  @37°C  suc2  A9  suc2A9, Akex2 
O  +  -- 
OH  +  - 
OI  +  - 
OKI  +  + 




Aochl strains expressing the above constructs were tested for the ability to grow on 
rich media at 37°C. suc2A9 and suc2A9 Akex2 strains expressing the above constructs 
were tested for the ability to grow on yeast extract peptone-sucrose-containing media 
at 30°C.  The Aochl strain is temperature sensitive, being unable to grow at 37°C. 
Efficient Kex2p-dependent Invertase Secretion 
Yeast strain SEY6210, which lacks a functional SUC2 gene 
and is therefore unable to utilize sucrose, was transformed 
with plasmids  encoding the Ochlp-invertase fusion pro- 
teins  diagrammed  in Fig.  1.  The nomenclature used for 
portions of the various fusion proteins is as follows: O re- 
fers to Ochlp, H  symbolizes the HA epitope, K indicates 
the Kex2p cleavage site, and I represents invertase. Only 
the Ochlp-invertase fusion proteins that contained an in- 
tervening Kex2p cleavage site, i.e., OKI and  OHKI, but 
not OI, were able to restore the ability of the suc2A9 strain 
to use sucrose as a carbon source (Table I). The ability to 
use sucrose was strictly dependent on the Kex2 protease 
because in an isogenic suc2A9 strain that lacks functional 
Kex2p, OKI and OHKI were no longer able to function- 
ally  complement  the  suc2A9  mutation  (Table  I).  These 
data indicate that some Ochlp-invertase fusion protein is 
exposed to the Kex2p enzyme, resulting in invertase secre- 
tion. However, the level of invertase secretion does not 
need to be high to yield a Suc  + phenotype, since as little as 
1% of the wild-type level expressed from the SUC2 pro- 
moter suffices (46). 
To determine  the  amount  of invertase  released  from 
OKI by Kex2p and subsequently secreted, the invertase 
activity of intact cells and cell lysates was quantitated (Ta- 
ble  II).  In  the  absence  of the  Kex2 cleavage site  (OI), 
~1% of the total cellular invertase was secreted. Cells ex- 
pressing either OKI or OHKI secreted ~70% of the inver- 
tase produced. The high level of invertase secreted from 
cells expressing either OKI or OHKI suggests that the ma- 
jority of fusion protein present in these cells at steady state 
is cleaved by Kex2p. To examine this finding further, we 
determined the amount of cleaved OHKI present in cells 
at steady state by immunoblot analysis using the anti-HA 
epitope antibody to  detect OH  and  OHKI.  Indeed, un- 
cleaved OHKI, which migrates at ,~150 kD (see Fig. 3), is 
virtually  undetectable  in  logarithmically  growing  cells 
(Fig. 2). Instead, the only HA-immunoreactive protein in 
the  strain  expressing OHKI appears  as  a  single band  at 
~66 kD that comigrates on SDS-PAGE with HA epitope- 
tagged  Oehlp.  Only  uncleaved  OHKI  is  detected  in  a 
Akex2 strain (data not shown). Together, these results in- 
dicate that the large majority of the OHKI fusion protein 
is cleaved by the late Golgi Kex2 protease. 
Cleavage of the OHKI Fusion Protein Is Rapid 
To determine the rate at which the OHKI fusion protein is 
cleaved by Kex2p, we performed a  pulse-chase analysis. 
The yeast strain SEY6210 containing the pOHKI plasmid 
was labeled at 30°C for 2 min and chased for 20 min (Fig. 
3). Aliquots of cells were removed at 0, 0.5, 1, 2, 5, 10, and 
20 min of chase.  Labeled proteins were immunoprecipi- 
tated  with  the  anti-HA  epitope  antibody,  separated  by 
SDS-PAGE, and visualized by autoradiography. At the 
0-rain time point, the uncleaved OHKI fusion protein is 
evident  migrating  at  ,'-~150 kD.  The  fusion  is  rapidly 
cleaved to yield HA epitope-tagged Ochlp (OH) and in- 
vertase, with a half-time of ~-,5 min. By 20 min, there is no 
detectable fusion protein remaining in the cell. Therefore, 
OHKI is rapidly (Fig. 3) and completely (Figs. 2  and 3) 
cleaved by the Kex2 protease. 
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Invertase activity (nmol/min/OD6c~ of cells) 
Pe~entage 
Construct  Pefiplasmic  Total  secreted 
OI  30  3000  1 
OKI  1105  1597  69 
OHKI  1059  1565  68 
The invertase activity of strain SEY6210 expressing the above constructs was mea- 
sured. Total activity from extracts prepared from lysed cells was determined by the 
method of Goldstein and Lampen (29). Whole cell extracts were prepared to measure 
periplasmic activity (44). Each value represents the mean of three experiments. The 
~50% reduction in the total invertase activity in OKI and OHKI ceils relative to Ol 
cells is probably due to release of invertase into the media, which would have been un- 
detected with the method used. 
Proteolytic Processing of Fusion Proteins Occurs 
in the TGN 
Although OHKI is not subject to the high degree of outer- 
chain glycosylation as seen with wild-type invertase (102), 
a  portion of the  fusion protein migrates  as  a  heteroge- 
neous population of higher molecular mass polypeptides 
before cleavage by Kex2p (see  the  5-min time point in 
Fig.  3). To examine whether this higher molecular mass 
"smear" represents fusion protein that had received outer- 
chain glycosylation, we used mannose linkage-specific an- 
tibodies (Fig. 4). Cells expressing OHKI were briefly pulse 
labeled as in Fig. 3 and then chased for 5 min before IP 
with anti-HA epitope antibody. The immunoprecipitated 
proteins were eluted from the anti-HA epitope antibody 
and subjected to a second IP with antibody specific for ei- 
ther the HA epitope, the oL-1,6-mannose  linkage, which is 
added in the cis/medial Golgi, or the o~-l,3-mannose link- 
age, which is added in the trans/TGN compartments. The 
150-kD OHKI fusion protein (Fig. 4) was immunoprecipi- 
tated  by  the  a-l,6-mannose-specific  antisera,  indicating 
that  it had  obtained at least the "initial" o~-l,6-mannose 
residue in the cis-Golgi. A  portion of the heterogeneous 
smear that migrates just slightly slower than the 150-kD 
protein could be  immunoprecipitated by the a-l,6-man- 
nose-specific antisera, but not the a-l,3-mannose-specific 
antisera (Fig. 4, compare lanes 2  and 3). We believe this 
represents  material  that  had  progressed  to  the  medial- 
Golgi, where the a-l,6 mannose outer-chain backbone was 
elongated,  but  had  not  moved  to  the  trans-Golgi,  and 
Figure 2. Uncleaved OHKI is un- 
detectable  at steady-state.  Whole 
cell  lysates  prepared  from  an 
equivalent  number of logarithmi- 
cally  growing  cells  from  strain 
SEY6210 expressing either OH or 
OHKI  were  separated  by  8% 
SDS-PAGE,  transferred to nitro- 
cellulose,  and  probed  with  anti- 
HA  epitope  hybridoma  serum- 
free culture supernatant used at a 
1,000-fold dilution. The immuno- 
blot was developed using chemilu- 
minescence detection (ECL; Am- 
ersham  Corp.).  Molecular  mass 
markers are indicated on the left. 
Figure 3. Cleavage of OHKI to OH occurs with a half-time of ~5 
min. SEY6210 cells expressing OHKI were labeled with Tran35S  - 
label for 2 rain at 30°C and chased for the times indicated. HA 
epitope-tagged  proteins from each time point were immunopre- 
cipitated with the anti-HA epitope antibody, separated  by SDS- 
PAGE, and visualized by autoradiography.  The OHKI and OH 
(generated from OHKI) proteins are indicated on the left. 
therefore had not obtained terminal ot-l,3-mannose link- 
ages. The higher molecular mass region of the smear was 
immunoprecipitable  by both  the  a-l,6-  and  a-l,3-man- 
nose-specific antibodies, indicating that this material had 
been exposed to the a-l,3  ManT in  the trans-Golgi.  Fi- 
nally, as indicated previously, OH is derived from OHKI 
by Kex2p cleavage in the TGN. This experiment indicated 
that within 5 min of synthesis, OHKI receives all the mod- 
ifications  indicative  of  transit  through  the  cis, medial, 
trans,  and TGN compartments.  Some  OH derived from 
OHKI is also immunoprecipitable by the a-l,6- and the 
ot-l,3-mannose-specific antibodies, but to a  lesser extent 
than the invertase-containing fusion protein. This may re- 
flect the fact that Ochlp has only four potential glycosyla- 
tion sites (65) compared to the 13 sites of invertase (13). 
Another  possibility  is  that  the  oligosaccharides  on  the 
Ochlp moiety are less heavily modified than those on the 
invertase moiety and therefore less immunoreactive (6). 
The experiments presented above indicate that OHKI 
rapidly receives outer-chain glycosyl modifications and is 
cleaved by  Kex2p,  but  do  not  clearly show  where  this 
cleavage is occurring. Three possibilities have been consid- 
ered: (a) OHKI is cleaved by Kex2p in the ER or in trans- 
port vesicles bound for the Golgi, (b) OHKI is statically 
retained in the cis-Golgi  and is cleaved in situ by newly 
synthesized Kex2p or Kex2p that may be recycling from 
the TGN (if this, in fact, occurs), and (c) OHKI travels to 
the TGN where it encounters Kex2p and is cleaved. 
If Ochlp is cleaved by Kex2p in the TGN, then the fu- 
sion protein should obtain outer-chain glycosylation in the 
medial-  and trans-Golgi  before cleavage. This appears to 
be the case in Fig. 3, but because the processing is so fast 
relative to the pulse time, the two modifications may be 
occurring simultaneously to different subpopulations of la- 
beled molecules, making  clear kinetic resolution  of the 
processes difficult. To circumvent this difficulty, we have 
used a secl8-1  temperature-sensitive strain, where trans- 
port of vesicles from the ER to the Golgi, and within the 
Golgi, is blocked at the restrictive temperature (31, 71). 
Isogenic SEC18 and sec18-1 strains expressing OHKI were 
labeled at 25°C  for 7.5 min. Cells were chased at the re- 
strictive temperature (37°C) for 0, 1, 2, and 5 min, and ra- 
diolabeled protein was immunoprecipitated with anti-HA 
epitope antibody. The antigens were then reimmunopre- 
cipitated with the linkage-specific antibodies to determine 
how far the proteins had progressed through the secretory 
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mannose linkages. SEY6210 cells expressing OHKI were labeled 
with Tran3SS-label for 2 min at 30°C and chased for 5 min at 30°C. 
Protein was immunoprecipitated with anti-HA epitope antibody. 
The immunoprecipitated  protein  was dissociated from  the  im- 
mune complex and divided into equivalent aliquots. The protein 
was then subjected to a second immunoprecipitation with either 
the  anti-HA epitope  antibody  or with ct-l,6- or ct-l,3-mannose 
linkage-specific  antisera.  The precipitated  proteins  were  sepa- 
rated  by SDS-PAGE and  visualized by autoradiography.  The 
OHKI and OH (generated from OHKI) proteins are indicated on 
the  left. Our interpretation  of how  far  each  protein  has  pro- 
gressed through the secretory pathway (see text) is indicated on 
the right. 
pathway before the  block in  transport.  In the  wild-type 
(SEC18) strain (Fig. 5, top panel), OHKI obtained outer- 
chain glycosylation, and the Golgi-modified fusion protein 
was rapidly cleaved to OH. During the chase period the 
levels of the c~-1,6- and c~-l,3-modified OHKI diminished, 
with  a  concomitant  increase  in  the  level  of OH.  Thus, 
a-l,6- and ct-l,3-modified OHKI is the precursor of OH. 
The same experiment, done in a sec18-1 strain, revealed 
that less fusion protein had progressed to the Kex2p com- 
partment in the sec18-1 strain than in the wild-type strain 
at the  earliest  timepoint  (compare the  levels  of OH de- 
rived from OHKI at the 0-min time points). Therefore, the 
kinetics  of vesicular transport  in sec18-1  cells  is  slightly 
slower than  in  wild-type cells,  even  at  the  "permissive" 
temperature of 25°C. This probably reflects a reduction in 
the activity of Secl8p. Despite this kinetic effect, it is clear 
that in sec18-1 cells (Fig.  5, bottom panel), conversion of 
OHKI to OH ceases after blocking vesicular transport at 
the restrictive temperature. This result is inconsistent with 
the  first  two possibilities  described  above.  OHKI is  not 
processed in the ER, in ER-derived transport vesicles, or 
in the cis-Golgi  either by newly synthesized Kex2p or by 
Kex2p recycling back from the TGN. If this were occur- 
ring,  the  Kex2p  present  in  the  OHKI-bearing compart- 
ments would be trapped there after the temperature shift 
and continue to be active. The result would be generation 
of OH from OHKI, which is not observed. 
This leaves the third possibility mentioned above: that 
OHKI is processed in the TGN. In support of this conclu- 
sion is the finding that neither the c~-1,6- nor ot-l,3-man- 
nose-modified OHKI is converted to OH after imposition 
of the  transport  block  (Fig.  5,  bottom panel)  in  sec18-1 
Figure 5.  Cleavage of OHKI occurs in the TGN. Isogenic SEC18 
and secl8-1 strains (SH104 with or without pSEC18) expressing 
OHKI were labeled with Tran35S-label for 7.5 min at 25°C. At the 
0-min time point, cells were shifted to 37°C and chased for the 
times indicated.  Radiolabeled,  HA epitope-tagged  protein  was 
immunoprecipitated with the anti-HA epitope antibody. The im- 
mune complexes were dissociated, and the protein  was divided 
into equivalent aliquots and subjected to a second immunopre- 
cipitation with either anti-HA epitope  antibody or the ct-l,6- or 
ct-l,3-mannose  linkage-specific  antibodies.  The  proteins  were 
separated  by SDS-PAGE and  visualized  by  autoradiography. 
The migration of the OHKI fusion protein  and the cleaved OH 
are indicated on the left. 
cells.  In fact, in sec18-1 cells,  the ct-l,3-mannosylated fu- 
sion protein was not cleaved by Kex2p even after 1 h  at 
37°C (data not shown). This result indicates that process- 
ing by Kex2p only occurs after modification in the medial- 
and trans-Golgi.  Furthermore, the processing must occur 
in a separate compartment, distinct from the medial-  and 
trans-Golgi.  Taken  together,  this  analysis  indicated  that 
conversion of OHKI to OH does not take place in the ER, 
or the cis-, medial-,  or trans-Golgi.  We conclude that the 
processing of OHKI to OH occurs in the Kex2p compart- 
ment, the TGN. 
Transit of the OHKI Fusion Protein to the TGN Is Not 
Induced by the lnvertase Moiety 
To examine whether transit of the OHKI fusion protein to 
the TGN is reflective of the  traffic pattern  of wild-type 
Ochlp or whether it was induced by the presence of the in- 
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molecule  that  more  closely resembles  wild-type  Ochlp. 
This construct,  termed  OKH (Fig.  1),  consists of Ochlp 
followed by the  Kex2 cleavage site and  the  HA epitope 
tag, but lacks the invertase moiety. Cleavage of the OKH 
protein  by Kex2p will  result  in  the  removal of the  HA 
epitope causing the protein to be refractory to IP by the 
anti-HA epitope antibody. OKH was expressed in isogenic 
suc2A9 and suc2zl9 Akex2 strains, and pulse-chase experi- 
ments were performed to follow the transit  of the  OKH 
protein  (Fig.  6).  In  the  absence  of  Kex2p  activity,  the 
OKH is immunoprecipitable with the anti-HA epitope an- 
tibody for an extended  period of time.  However, in  the 
presence of functional Kex2p, the OKH protein is rapidly 
cleaved by the  protease with  a  half-time  (~5  min) very 
similar to that seen for the OHKI fusion protein (Fig. 3). 
Thus, movement of the fusion protein to the late Golgi is 
not induced by the invertase moiety. 
To  test  directly  whether  HA  epitope-tagged  Ochlp 
(OH)  is  exposed  to  late  Golgi  compartments,  cells  ex- 
pressing OH were labeled briefly, chased for 30 rain, and 
immunoprecipitated  with  the  anti-HA  epitope  antibody 
followed by IP with the  linkage-specific antibodies  (Fig. 
7). We found that de novo-synthesized OH (i.e., not gen- 
erated  by  cleavage  of  OHKI)  was  immunoprecipitable 
with the et-l,6-mannose-specific antisera and,  to a  lesser 
degree,  with  et-l,3-mannose-specific  antisera.  Although 
only a  small amount of OH is immunoprecipitable with 
the a-l,3-mannose-specific antisera, this amount is similar 
to  the  amount  of a-l,3-mannose-bearing  OH generated 
from OHKI, which  is known  to  have reached  the  TGN 
(Fig. 4). The presence of comparable levels of o~-l,3-Man 
linkages on de novo-synthesized OH and OH generated 
from OHKI, suggests that at least some of the de novo- 
synthesized  OH  has  been  exposed  to  the  et-l,3-ManT, 
which is resident in both the trans-Golgi and the TGN (33). 
These results (Figs. 6 and 7) indicate that OKH and OH 
undergo a similar traffic pattern as OHKI, and by extrapo- 
lation, we suggest that wild-type Ochlp may do so as well. 
Figure Z De novo-synthesized OH bears a-l,6-, and to a lesser 
degree,  a-l,3-mannose linkages.  SEY6210 cells expressing  OH 
were labeled for 5 rain at 30°C and chased for 30 min. Protein was 
immunoprecipitated with the anti-HA epitope antibody. The im- 
mune complex was dissociated  by heating,  and the precipitated 
protein was  divided  into  equivalent  aliquots.  The protein was 
then subjected  to a second immunoprecipitation with either the 
anti-HA epitope antibody or the ct-l,6- or c~-l,3-mannose link- 
age-specific antibodies.  The proteins were separated by SDS- 
PAGE and visualized by autoradiography. 
Ochlp Is Not Rapidly Transported to the Vacuole after 
Encountering the TGN 
The  experiments presented  so far indicate  that  OH and 
OHKI rapidly travel to the TGN. To determine the fate of 
Ochlp  after encountering  the  late  Golgi, we first  exam- 
ined  the  stability  of both  de  novo-synthesized OH  and 
OH derived from OHKI (Fig. 8). Cells were labeled for 10 
rain at 30°C, chased for 180 min, and aliquots of cells were 
removed at various time points. OH (Fig. 8 A) and OH de- 
rived from OHKI (Fig. 8 B) have similar half-lives of ~60 
min. This half-life is an order of magnitude longer than the 
half-time of transit of OHKI (Fig. 3) or OKH (Fig. 6) to 
the TGN. OH is stable in a Apep4 strain (data not shown) 
indicating that the eventual degradation of Ochlp occurs 
in the vacuole (38). These findings indicate that Ochlp is 
Figure 6.  Rapid transit to the TGN is not dependent on the in- 
vertase  moiety.  Isogenic  KEX2  and  Akex2 strains  expressing 
OKH were  labeled with  Tran35S-label for 2  min  at  30°C and 
chased for the times indicated. The proteins were immunoprecip- 
itated  with  the  anti-HA epitope  antibody,  separated  by SDS- 
PAGE, and visualized by autoradiography. 
Figure 8. De novo-synthesized OH and OH derived from OHKI 
persist in the cell 12-fold longer than the time taken to reach the 
TGN. SEY6210 cells expressing  either OH or OHKI were la- 
beled with Tran35S-label for 10 min at 30°C and chased  for the 
times indicated. The proteins were immunoprecipitated with the 
anti-HA epitope antibody, separated by SDS-PAGE, and visual- 
ized by autoradiography. The migration of OH and OHKI are in- 
dicated. 
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late Golgi. 
To confirm these results, we compared the subcellular 
fractionation behavior of an IMP of the vacuole, the 100- 
kD subunit of the H+-ATPase (21)  (Fig. 9 A), to that of 
OH,  either  synthesized  de novo (Fig.  9  B)  or generated 
from OHKI (Fig. 9  C). These strains also expressed HA 
epitope-tagged Kex2p that will be discussed below. A  ly- 
sate ($1)  was prepared from strains expressing both HA 
epitope-tagged  Kex2p  and  OH,  or  both  HA  epitope- 
tagged Kex2p and OHKI. The $1 fractions were separated 
by differential centrifugation at 10,000 g into pellets (P10) 
Figure 9.  The compartment(s) bearing de novo-synthesized OH 
and OH derived from OHKI have similar buoyant densities, dis- 
tinct  from that of the vacuole and the Kex2-compartment. Ly- 
sates  (S1)  were  prepared  from zakex2 strains  expressing  HA 
epitope-tagged Kex2p and either (A and B) OH or (A and C) 
OHKI and separated by differential  centrifugation  into a pellet 
(PIO) and a Golgi-enriched  supernatant ($10). A portion of each 
S10 was centrifuged  to equilibrium  in 2540%  (wt/wt)  sucrose 
gradients.  The gradients  were fractionated, and (D) the sucrose 
concentration of each gradient fraction was determined by refrac- 
tometry. (A) The proteins in 2 ~1 of the S1, P10, and S10 were 
separated by 8% SDS-PAGE and analyzed  by immunoblotting 
with the anti-yeast vacuolar H+-ATPase 100-kD  subunit at a 
1:4,000 dilution.  (B and C) The proteins in 2 ~1 of the S1, P10, 
and S10, as well as 15 I~1 of each gradient fraction, were separated 
by 8%  SDS-PAGE and  analyzed  by immunoblotting with  the 
anti-HA epitope antibody at a 1:1,000 dilution. Protein was visu- 
alized using the chemiluminescence  detection system. 
and  supernatants  (S10).  The  S1,  P10,  and  S10  fractions 
were  then  probed  by immunoblotting  with  an  antibody 
specific for the 100-kD subunit of the H+-ATPase (21) and 
with the anti-HA epitope antibody to detect OH and HA 
epitope-tagged Kex2p. While the large majority of the HA 
epitope-tagged  Ochlp  and  Kex2p  fractionate  into  the 
10,000-g supernatant (S10) (Fig. 9, B and C; left), the vacu- 
olar marker was exclusively found in the  10,000-g pellets 
(P10)  (Fig.  9 A).  This again indicates  that  after OH en- 
counters the TGN it does not reside in the vacuole. 
Ochlp Returns to the cis-Golgi after TGN Transit 
To examine whether OH simply remains in the TGN after 
transit  there,  or  whether  it returns  to  the  cis-Golgi,  the 
Golgi-enriched  $10  supernatants  were  fractionated  by 
isopycnic  centrifugation  on  25-40%  sucrose  gradients 
(Fig. 9, B-D), and the distribution of OH and HA epitope- 
tagged Kex2p, which is a marker of the TGN, was exam- 
ined by immunoblotting. In both gradients Ochlp migrated 
in a peak (predominantly fractions 6-9) corresponding to 
~28-32%  (wt/wt)  sucrose, whereas a  more defined peak 
of Kex2p  (predominantly  fractions  4-5)  was  evident  at 
about 34% sucrose (Fig. 9, B-D). Thus, at steady state, the 
bulk  of OH,  irrespective of whether  it  is synthesized  de 
novo or  derived from OHKI, resides  in  a  compartment 
physically separable  from both  the  Kex2p compartment 
and the vacuole. 
To determine if the compartment that contained OH at 
steady state was indeed  the cis-Golgi,  we localized wild- 
type Ochlp. We used an antisera directed against the lu- 
minal domain of Ochlp for this purpose. When used to im- 
munoprecipitate protein from whole cell extracts (Fig. 10 
A),  the  antibody  recognizes  a  protein  with  an  apparent 
molecular mass of 66 kD in the wild-type strain that is ab- 
sent in the Aochl cells. To localize Ochlp, wild-type cells 
were labeled for 2 min at 30°C and chased for 60 min. A 
Golgi-enriched  $10  supernatant  was  prepared  from  la- 
beled cells and was fractionated on a 25-40% sucrose gra- 
dient.  Protein  from each gradient  fraction was immuno- 
precipitated  with  the  anti-Ochlp  antisera  and  separated 
by SDS-PAGE (Fig. 10 B). Ochlp was found in fractions 
7-10  corresponding  to  28-32%  sucrose.  Thus,  the  wild- 
type Ochlp compartment migrates at the same density ob- 
served for the  compartment bearing HA epitope-tagged 
Ochlp, suggesting that the epitope-tagged protein returns 
to the cis-Golgi after encountering the TGN. 
In another approach to demonstrate that the Ochlp fu- 
sion proteins reside in the cis-Golgi at steady state, we ex- 
amined whether cells expressing only an Ochlp construct 
that rapidly encounters the Kex2p compartment can glyco- 
sylate invertase to the same degree as wild-type cells. In- 
vertase  provides  a  sensitive  measure  of the  outer-chain 
glycosylation because it is hyper-glycosylated as it passes 
through the Golgi (24). Since Ochlp is responsible for ini- 
tiation of this extensive glycosylation (64, 80), a significant 
decrease in  Ochlp  activity should be evident as reduced 
glycosylation of invertase. Therefore, various strains (wild- 
type, Aochl , and Aochl expressing wild-type Ochlp [O], 
OH, or OKH) were labeled, and the glycosylation state of 
endogenous invertase was examined by immunoprecipita- 
tion and SDS-PAGE (Fig.  11).  As expected, invertase is 
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Ochlp  construct  that  rapidly encounters  the  TGN. Wild-type 
(SEY6210)  cells  and  Aochl  cells  expressing  either  wild-type 
Ochlp (pO), HA epitope-tagged Ochlp (pOH), or the OKH fu- 
sion construct were labeled with Tran35S-label for 30 min at 30°C. 
Protein was immunoprecipitated with an anti-invertase  antibody, 
separated by SDS-PAGE, and visualized by autoradiography. 
Figure 10.  Wild-type  Ochlp  resides  in  a  compartment with  a 
buoyant density  between 28--32% sucrose.  (A) Wild-type  cells 
and Aochl cells were labeled with Tran35S-label for 2 min at 30°C 
and chased for 60 min. (A) Radiolabeled protein was immuno- 
precipitated with  the rabbit polyclonal  anti-Ochlp luminal  do- 
main antibody, separated by SDS-PAGE, and visualized by auto- 
radiography.  (B) A  Golgi enriched (S10) fraction was prepared 
from radiolabeled wild-type (SEY6210) ceils and centrifuged  to 
equilibrium  in a 25-40%  (wt/wt)  sucrose  gradient.  Protein was 
immunoprecipitated from each gradient fraction with  the anti- 
Ochlp luminal domain antibody,  separated by SDS-PAGE, and 
visualized by autoradiography.  The migration of Ochlp is indi- 
cated by a bar.  (C) The sucrose  concentration of each gradient 
fraction was determined by refractometry. 
hyper-glycosylated in the wild-type strain, migrating as a 
heterogeneous smear. In contrast, invertase in the Aochl 
strain migrates as a distinct band because outer-chain glyco- 
sylation cannot be initiated. Expression of either wild-type 
Ochlp  (O)  or  HA  epitope-tagged  Ochlp  (OH)  in  the 
Aochl strain results in wild-type glycosylation of invertase. 
Significantly,  expression  of OKH,  which  encounters  the 
Kex2p compartment with a half-time of 5 min (Fig. 6), also 
results in hyper-glycosylation of invertase, suggesting that 
an Ochlp moiety known to transit to the late Golgi is fully 
active.  Taken  together,  these  data  suggest  a  model  in 
which the steady-state distribution of epitope-tagged Ochlp 
is in the cis-Golgi, yet the protein undergoes rapid move- 
ment through later compartments and is retrieved. 
In an effort to determine if the behavior of HA epitope- 
tagged Ochlp is representative of the  wild-type protein, 
we  examined the  stability of wild-type  Ochlp  and  com- 
pared it to  OH (Fig.  12).  Wild-type cells expressing OH 
were labeled for 10 min at 30°C,  chased for 240 min, and 
aliquots of cells were analyzed by IP with the anti-Ochlp 
antisera followed by SDS-PAGE. The anti-Ochlp antisera 
recognizes both wild-type Ochlp and OH, which migrates 
more slowly through the gel due to the presence of the HA 
epitope tag. The half-life of the wild-type protein is ~2.5- 
fold  longer  than  the  tagged  protein.  Although  the  HA 
epitope tag does not seem to perturb the steady-state dis- 
tribution of the protein (compare Figs. 9 and 10), it may af- 
fect the kinetics of recycling, which will be discussed below. 
Discussion 
Most recent models for the  retention of type II IMPs in 
the  Golgi suggest that these proteins cease their forward 
movement when they reach the appropriate compartment. 
It has been suggested that this process could be mediated 
by entry into a large oligomer, interaction with a putative 
Golgi matrix, or by virtue of a cholesterol-mediated gradi- 
ent of membrane thickness across the Golgi stack (see In- 
troduction).  In  contrast to  these  models we  have  found 
that the cis-Golgi protein used in our analyses can move 
past the cis compartment and subsequently be retrieved. 
The yeast Golgi apparatus can be biochemically subdi- 
vided into at least four compartments (see Introduction). 
By analogy to mammalian Golgi, we refer to these as cis, 
Figure 12.  Wild-type  Ochlp has a slightly longer half-life than 
HA epitope-tagged Ochlp. Wild-type  (SEY6210) cells express- 
ing the HA epitope-tagged Ochlp construct  (pOH) were labeled 
with Tran35S-label for 10 min at 30°C and chased for the times in- 
dicated. Protein was immunoprecipitated with the anti-Ochlp an- 
tibody, separated by SDS-PAGE, and visualized by autoradiog- 
raphy. The migration of Ochlp and HA_ epitope-tagged Ochlp is 
indicated.  The amount of Ochlp present at each time point was 
quantitated  by Phosphorimager (Molecular  Dynamics,  Sunny- 
vale, CA) analysis. 
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be a resident of the cis-Golgi in yeast. At the distal end of 
the Golgi is the TGN compartment that houses the Kex2p 
endoprotease responsible for the maturation of pro--a-fac- 
tor and pro-killer toxin in S. cerevisiae. 
To study Golgi localization in yeast, we have analyzed 
the traffic pattern of a  series of Ochlp-invertase fusion 
proteins.  The most  instructive protein consisted  of full- 
length Ochlp, an HA epitope tag, a Kex2p cleavage site, 
and full-length invertase  (OHKI). Surprisingly, we  have 
found  that  OHKI  is  not  efficiently retained  in  the  cis- 
Golgi. This protein moves to the TGN, where it is pro- 
cessed by Kex2p, resulting in invertase secretion. Remark- 
ably, this cleavage event occurs with a half-time of ~5 min, 
and is so efficient that the uncleaved fusion protein is un- 
detectable at steady state. The oligosaccharides of the fu- 
sion  protein  receive  medial  (elongated  ct-l,6-mannose) 
and trans  (terminal o~-l,3-mannose) modifications before 
Kex2p cleavage. This indicates that the cleavage of OHKI 
occurs after the fusion protein has encountered the c/s-, 
medial-,  and  trans-Golgi.  Newly  synthesized  Kex2p  in 
transit through the cis compartment, or Kex2p recycling 
through the early Golgi, are not responsible for cleavage 
of OHKI. Thus, processing of OHKI occurs in the TGN. 
OH is  ultimately degraded in the vacuole in a  PEP4- 
dependent fashion. We found that the half-life of OH deg- 
radation, irrespective of whether it is synthesized at the 
ER or generated in the TGN, is 60 rain. This turnover time 
is 12-fold longer than the time required to reach the TGN, 
indicating that the OH does not move directly from the 
TGN to the vacuole, a result that was confirmed by subcel- 
lular fractionation. We have also shown that the bulk of 
both ER-synthesized OH and TGN-generated OH resides 
in a compartment with the same density as wild-type Ochlp 
and a lower buoyant density than the TGN. This indicates 
that OH derived from OHKI in the TGN is correctly local- 
ized to the cis-Golgi at steady state despite its rapid transit 
through the TGN. Finally, we found that cells exclusively 
expressing an Ochlp construct that rapidly moves through 
the TGN can glycosylate invertase as efficiently as wild-type 
cells. Taken together, these findings indicate that the cis- 
Golgi protein Ochlp is capable of recycling from the TGN. 
The rapid transit time (~5 min) to the TGN, although 
slower than the ~1.5 min required for invertase to acquire 
outer-chain oligosaccharide modification (86), is much too 
fast to represent efficient retention in the cis-Golgi. Never- 
theless, the finding that OH recycles does not rule out the 
possibility that there is a "statically retained" state. It does 
imply, however, that entry into this putative retained state 
is not an efficient process. In fact, it is difficult to imagine a 
model that allows for distinct protein compositions in dif- 
ferent cisternae that does not involve at least a transiently 
retained state. One can view the process of retention as a 
pause in a particular compartment. At one extreme, the 
protein "pauses" for its entire lifetime (that is, it has a high 
affinity for the retained state), after which it is released 
and  degraded.  In  the  other extreme, the  pause  is  short 
compared to the lifetime of the protein (a low affinity for 
the  retained  state),  and  after  continued  movement  the 
protein can be retrieved from distal compartments. This 
recycling continues until the protein finally escapes the re- 
trieval system and is degraded. The degree to which differ- 
ent  proteins  pause  may  vary.  In  this  kinetic  retention 
model  epitope-tagged  Ochlp  would  pause  only briefly, 
possibly because of a low affinity for the putative retained 
state, but this effect would be sufficient to result in the pre- 
dominantly c/s-Golgi distribution of OH at steady state. 
These findings are in accordance with a recent study of 
the localization of Mnnlp (32), which is the terminal tx-l,3- 
ManT in yeast. Mnnlp is distinctive because of its approx- 
imately equal distribution between two physically separa- 
ble compartments, one of which contains Kex2p (33); that 
is, Mnnlp resides in both the trans-Golgi and TGN com- 
partments. Recently, Graham and Krasnov (32) used a fu- 
sion protein consisting of the Mnnlp transmembrane do- 
main followed by a Kex2p site and invertase to examine 
the extent of exposure of this protein to the Kex2p en- 
zyme. They found that 85% of the protein was rapidly pro- 
cessed by Kex2p, which is more than could be accounted 
for by the dual steady-state distribution of Mnnlp in the 
trans-Golgi  and  TGN.  Therefore,  they  suggested  that 
Mnnlp may cycle between the trans-Golgi and TGN. In 
• the same study, however, it was also shown that the lumi- 
nal domain of Mnnlp, which was not included in the fu- 
sion  protein, also contains  localization information. Ac- 
cordingly, the authors pointed out that the disproportionately 
high exposure of the fusion protein to the TGN might be 
due to the absence of the Mnnlp luminal domain. Our re- 
sults  with  full-length  Ochlp  constructs  tend  to  support 
Graham and Krasnov's suggestion that Mnnlp cycles be- 
tween the trans and TGN compartments. 
Another  outcome  of our  analyses  with  Ochlp  is  the 
clear  demonstration  of a  retrograde  transport  pathway 
from the TGN to the cis-Golgi.  This extends the recent 
demonstration by Schrrder et al. (88) that a type I medial- 
Golgi protein, Emp47, has a recycling itinerary that extends 
from the trans-Golgi (i.e., the et-l,3-ManT compartment) 
to the  ER.  There are  also several precedents for retro- 
grade transport through the Golgi apparatus in mamma- 
lian cells. First, several residents of the secretory pathway 
have been shown to obtain oligosaccharide modifications 
that  occur in later compartments. For example, the  oli- 
gosaccharides of the ER resident calreticulin are  termi- 
nally  galactosylated,  a  modification  that  occurs  in  the 
trans-Golgi (76). Likewise, two medial-Golgi resident pro- 
teins, GIMPc (112) and MG160 (30), have been shown to 
bear terminal sialic acid residues, which are added in the 
TGN. In addition, the N-acetylglucosaminyl-transferase I 
enzyme, a resident of the medial/trans-Golgi, can undergo 
retrograde transport to the early Golgi (40). Second, sev- 
eral  toxins  which  are  taken  up  by endocytosis, such  as 
Pseudomonas exotoxin, ultimately gain access to the cyto- 
sol via the ER (73, 75) and their cytotoxicity can be in- 
creased by placing a KDEL sequence at their carboxy ter- 
mini (93). And finally, it was recently shown that a short 
peptide that contains KDEL at the carboxy terminus can 
move via retrograde transport from the TGN to the ER (60). 
Although an epitope-tagged version of Ochlp has been 
used for many of the experiments presented, a series of ex- 
periments has been performed to determine if the traffic 
pattern of the fusion protein is representative of the wild- 
type protein. One could envision that the bulky invertase 
moiety appended to the carboxy terminus of Ochlp could 
somehow interfere with retention, perhaps by inhibiting 
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the case because a construct without the invertase moiety 
encounters the TGN with the same kinetics as the inver- 
tase-bearing  fusion.  In  addition,  we  have  shown  that 
Ochlp, altered only by the addition of an HA epitope tag 
(OH),  obtained  the  a-l,6-  and  ot-l,3-mannose  linkages 
characteristic of transit through the medial and trans com- 
partments.  This  indicates  that  neither  the  specific  se- 
quences present in the Kex2 cleavage site nor invertase 
are responsible for continued forward movement. Finally, 
Ochlp--invertase  fusion  protein-dependent  secretion  of 
invertase is not dependent on the HA epitope tag (Tables 
I and II). Thus, movement to distal Golgi compartments is 
not dependent on any of the specific sequences appended 
to the carboxy terminus of Ochlp. However, it is possible 
that modification of the carboxy terminus itself, indepen- 
dent of the protein sequence (HA epitope, Kex2 site, or 
invertase), is responsible for this traffic pattern. 
Several experiments suggest that epitope-tagged Ochlp 
behaves  similarly  to  the  native  protein.  First,  epitope- 
tagged Ochlp appears to be localized to the same com- 
partment as wild-type Ochlp at steady state (Figs. 9 and 
10).  In addition, the fusion constructs appear to be fully 
active, as measured by their ability to glycosylate inver- 
tase, again suggesting that the proteins are correctly local- 
ized at steady state. However, it is important to note that 
the half-life of wild-type Ochlp is  about 2.5-fold longer 
than the half-life of epitope-tagged Ochlp. There are sev- 
eral possible reasons for this difference. One is that the 
wild-type  protein  may  enter  into  the  putative  retained 
state with greater efficiency than the epitope-tagged pro- 
tein. The majority of the Ochlp would enjoy a lengthy re- 
tained  state,  and  only a  small percentage of the  Ochlp 
would travel to the late Golgi where it could be either re- 
trieved by retrograde transport or shunted to the vacuole 
for degradation. If this is true, then the rapid flux demon- 
strated by the tagged molecule OKH, for example, could 
indicate that a retention signal exists at the carboxy termi- 
nus of Ochlp that is disrupted by the addition of the HA 
epitope. Alternatively, both wild-type and epitope-tagged 
Ochlp may enter into the putative retained state with a 
similar  efficiency, but  retrieval  from  the  TGN  may be 
compromised by the presence of the epitope tag, resulting 
in diversion to the vacuole. 
Nevertheless,  despite  the  kinetic  difference  between 
OH and wild-type Ochlp, it is now apparent that the local- 
ization mechanism of Ochlp involves a retrograde trans- 
port component. The majority of epitope-tagged Ochlp is 
transported to the late Golgi and must be recycled back to 
the  cis-Golgi  using  a  retrograde  transport  system.  It  is 
likely that the wild-type protein uses the same transport 
system, at least to some extent. It remains to be deter- 
mined whether recycling plays a major or supporting role 
in the localization of the wild-type protein. 
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